OTCMKTS:DGNOF DIAGNOS (DGNOF) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free DGNOF Stock Alerts $0.21 0.00 (-2.11%) (As of 04/26/2024 08:54 PM ET) Add Compare Share Share Today's Range$0.21▼$0.2150-Day Range$0.18▼$0.2552-Week Range$0.18▼$0.43Volume33,000 shsAverage Volume24,184 shsMarket Capitalization$16.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get DIAGNOS alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About DIAGNOS Stock (OTCMKTS:DGNOF)DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Read More DGNOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DGNOF Stock News HeadlinesApril 19, 2024 | americanbankingnews.comDIAGNOS (OTCMKTS:DGNOF) Trading Down 0.7%April 16, 2024 | globenewswire.comDIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certificationApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 9, 2024 | globenewswire.comDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11thApril 3, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsApril 2, 2024 | globenewswire.comDIAGNOS Welcomes Dr. Philippe Couillard to its Board of DirectorsMarch 22, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementMarch 4, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.February 29, 2024 | globenewswire.comDIAGNOS Welcomes Mr. Michael Braeuel to its Board of DirectorsFebruary 27, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementFebruary 23, 2024 | globenewswire.comDiagnos Announces Variation in One Insider Ownership of Common SharesFebruary 21, 2024 | globenewswire.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyDecember 8, 2023 | nytimes.comBest of 2023See More Headlines Receive DGNOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today4/28/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:DGNOF CUSIPN/A CIKN/A Webwww.diagnos.ca Phone(450) 678-8882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins-1,553.79% Pretax Margin-1,032.49% Return on EquityN/A Return on Assets-297.10% Debt Debt-to-Equity RatioN/A Current Ratio0.79 Quick Ratio0.79 Sales & Book Value Annual Sales$370,000.00 Price / Sales43.26 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-10.44Miscellaneous Outstanding Shares76,650,000Free FloatN/AMarket Cap$16.00 million OptionableNot Optionable Beta0.20 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Andre LarenteCEO, President & Executive ChairmanMr. Marc-André MassueVP of Finance, CFO & SecretaryMr. Yves-Stéphane CoutureChief Operating OfficerMr. Martin BelandDirector of MarketingKey CompetitorsNextech3D.AIOTCMKTS:NEXCFReliq Health TechnologiesOTCMKTS:RQHTFVictory Square TechnologiesOTCMKTS:VSQTFVoyager DigitalOTCMKTS:VYGVFPharma-Bio ServOTCMKTS:PBSVView All Competitors DGNOF Stock Analysis - Frequently Asked Questions How have DGNOF shares performed in 2024? DIAGNOS's stock was trading at $0.3050 at the beginning of the year. Since then, DGNOF stock has decreased by 31.5% and is now trading at $0.2088. View the best growth stocks for 2024 here. How were DIAGNOS's earnings last quarter? DIAGNOS Inc. (OTCMKTS:DGNOF) issued its earnings results on Wednesday, February, 28th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.04 million for the quarter. How do I buy shares of DIAGNOS? Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DGNOF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
